Cytomegalovirus pUL97 Kinase Inhibitors [MoA] class drugs

1 result
  • livtencity - maribavir tablet, coated

    (Maribavir)
    Takeda Pharmaceuticals America, Inc.
    Livtencity treats post-transplant cytomegalovirus (CMV) infection/disease in adults and pediatric patients (12+ years, ≥35 kg) when resistant to ganciclovir, valganciclovir, cidofovir, or foscarnet.